The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being ...

Moderna is one of the pharmaceutical companies best known for developing the messenger RNA vaccine against Covid-19.

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna ( NASDAQ: MRNA) by the ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...

Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a ...

The bird flu shot contract was awarded to Moderna in the Biden administration's final days, sending the company's stock up 13 ...

The U.S. government awarded Moderna $590 million in January to advance the development of its bird flu vaccine ...

The vaccine advisory panel played a key role during the pandemic, debating whether to authorize mRNA-based Covid vaccines ...

Moderna (MRNA) stock is reacting to reports of the US Department of Health and Human Services (HHS) reconsidering its bird flu vaccine deal with the drug maker. Yahoo Finance senior health reporter ...